[go: up one dir, main page]

WO2006001848A3 - Quantum dots as high-sensitivity optical sensors and biocompatible imaging probes, compositions thereof, and related methods - Google Patents

Quantum dots as high-sensitivity optical sensors and biocompatible imaging probes, compositions thereof, and related methods Download PDF

Info

Publication number
WO2006001848A3
WO2006001848A3 PCT/US2005/004310 US2005004310W WO2006001848A3 WO 2006001848 A3 WO2006001848 A3 WO 2006001848A3 US 2005004310 W US2005004310 W US 2005004310W WO 2006001848 A3 WO2006001848 A3 WO 2006001848A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
quantum dots
optical sensors
related methods
imaging probes
Prior art date
Application number
PCT/US2005/004310
Other languages
French (fr)
Other versions
WO2006001848A2 (en
Inventor
Christoph A Naumann
Bruce A Young
Eric C Long
Original Assignee
Advanced Res & Tech Inst
Christoph A Naumann
Bruce A Young
Eric C Long
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Res & Tech Inst, Christoph A Naumann, Bruce A Young, Eric C Long filed Critical Advanced Res & Tech Inst
Publication of WO2006001848A2 publication Critical patent/WO2006001848A2/en
Publication of WO2006001848A3 publication Critical patent/WO2006001848A3/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Ceramic Engineering (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Luminescent Compositions (AREA)

Abstract

The invention provides a semiconductor nanoparticle with improved stability and biocompatibility properties. Accordingly, the present invention provides a nanoparticle that is capped with two separate protective layers: an inner inert layer and an outer inert layer and related in vitro and in vivo methods of use.
PCT/US2005/004310 2004-02-12 2005-02-11 Quantum dots as high-sensitivity optical sensors and biocompatible imaging probes, compositions thereof, and related methods WO2006001848A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54396504P 2004-02-12 2004-02-12
US60/543,965 2004-02-12

Publications (2)

Publication Number Publication Date
WO2006001848A2 WO2006001848A2 (en) 2006-01-05
WO2006001848A3 true WO2006001848A3 (en) 2007-01-25

Family

ID=35782210

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/004310 WO2006001848A2 (en) 2004-02-12 2005-02-11 Quantum dots as high-sensitivity optical sensors and biocompatible imaging probes, compositions thereof, and related methods

Country Status (1)

Country Link
WO (1) WO2006001848A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103554477A (en) * 2008-02-25 2014-02-05 纳米技术有限公司 Semicondcutor nanoparticle capping agents
US8766315B2 (en) 2010-03-22 2014-07-01 Samsung Display Co., Ltd. Quantum dot-block copolymer hybrid, methods of fabricating and dispersing the same, light emitting device including the same, and fabrication method thereof
US8847197B2 (en) 2009-09-23 2014-09-30 Nanoco Technologies Ltd. Semiconductor nanoparticle-based materials
US8957401B2 (en) 2009-09-23 2015-02-17 Nanoco Technologies, Ltd Semiconductor nanoparticle-based materials
US9159590B2 (en) 2010-04-01 2015-10-13 Nanoco Technologies, Ltd. Encapsulated nanoparticles

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0409877D0 (en) 2004-04-30 2004-06-09 Univ Manchester Preparation of nanoparticle materials
GB2429838B (en) 2005-08-12 2011-03-09 Nanoco Technologies Ltd Nanoparticles
US8563348B2 (en) 2007-04-18 2013-10-22 Nanoco Technologies Ltd. Fabrication of electrically active films based on multiple layers
US20080264479A1 (en) 2007-04-25 2008-10-30 Nanoco Technologies Limited Hybrid Photovoltaic Cells and Related Methods
US8784701B2 (en) 2007-11-30 2014-07-22 Nanoco Technologies Ltd. Preparation of nanoparticle material
GB0814458D0 (en) 2008-08-07 2008-09-10 Nanoco Technologies Ltd Surface functionalised nanoparticles
GB0820101D0 (en) 2008-11-04 2008-12-10 Nanoco Technologies Ltd Surface functionalised nanoparticles
GB0821122D0 (en) 2008-11-19 2008-12-24 Nanoco Technologies Ltd Semiconductor nanoparticle - based light emitting devices and associated materials and methods
EP4021909A4 (en) 2019-08-29 2023-08-30 David C. Martin BIOFUNCTIONAL THIOPHENE MONOMERS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NIEMEYER: "Nanoparticles, Proteins And Nucleic Acids: Biotechnology Meets Materials Science", ANGEWANDTE CHEMIE (INTERNATIONAL EDITION), vol. 40, 2001, pages 4128 - 4158, XP003003923 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103554477A (en) * 2008-02-25 2014-02-05 纳米技术有限公司 Semicondcutor nanoparticle capping agents
US8847197B2 (en) 2009-09-23 2014-09-30 Nanoco Technologies Ltd. Semiconductor nanoparticle-based materials
US8957401B2 (en) 2009-09-23 2015-02-17 Nanoco Technologies, Ltd Semiconductor nanoparticle-based materials
US9543481B2 (en) 2009-09-23 2017-01-10 Nanoco Technologies Ltd. Semiconductor nanoparticle-based materials
US8766315B2 (en) 2010-03-22 2014-07-01 Samsung Display Co., Ltd. Quantum dot-block copolymer hybrid, methods of fabricating and dispersing the same, light emitting device including the same, and fabrication method thereof
US9159590B2 (en) 2010-04-01 2015-10-13 Nanoco Technologies, Ltd. Encapsulated nanoparticles

Also Published As

Publication number Publication date
WO2006001848A2 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
WO2006001848A3 (en) Quantum dots as high-sensitivity optical sensors and biocompatible imaging probes, compositions thereof, and related methods
Qin et al. Nanodiamonds: Synthesis, properties, and applications in nanomedicine
Haidary et al. Nanoporous silicon as drug delivery systems for cancer therapies
WO2005087168A3 (en) Radiopaque, coaxial orthopedic tether design and method
WO2010005725A3 (en) Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
WO2008122596A3 (en) Curable therapeutic implant composition
WO2008003298A3 (en) Manufacture, method, and use of active substance-releasing medical products for permanently keeping blood vessels open
WO2005089106A3 (en) Degradable nanoparticles
WO2007002662A3 (en) Anti-inflammatory, radioprotective, and longevity enhancing capabilities of cerium oxide nanoparticles
US20170119814A1 (en) Therapeutic nanoparticles and methods thereof
WO2009149362A3 (en) Integrated nanofluidic analysis devices, fabrication methods and analysis techniques
WO2008044236A3 (en) Improved release of statins in the intestine
WO2006010083A3 (en) Biodegradable nanoparticles
WO2010021757A3 (en) Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
WO2009009666A3 (en) Method to enhance osteoblast functionality and measure electrochemical properties for a medical implant
WO2010017094A3 (en) CURCUMIN DERIVATIVES FOR AMYLOID-β PLAQUE IMAGING
TW200635612A (en) Use of cyanine dyes for the diagnosis of proliferative diseases
WO2006094737A3 (en) Gastroresistant pharmaceutical formulations containing rifaximin
WO2012040623A3 (en) Nanostructured gels capable of controlled release of encapsulated agents
WO2010005721A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
WO2006092722A8 (en) Peptidomimetic compounds and preparation of biologically active derivatives
EP2305316A3 (en) Diphosphorylated glycopeptide imaging agent for fibrosis
WO2007019184A3 (en) Oral suspension of prednisolone acetate
WO2006130702A3 (en) Modified release formulations of antihypertensive drugs
WO2006093516A3 (en) Peptide-coated nanoparticles with graded shell compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase